Cargando…
Treatment as Required versus Regular Monthly Treatment in the Management of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
BACKGROUND: To investigate whether treatment as required ‘pro re nata’ (PRN) versus regular monthly treatment regimens lead to differences in outcomes in neovascular age-related macular degeneration (nAMD). Regular monthly administration of vascular endothelial growth factor (VEGF) inhibitors is an...
Autores principales: | Schmucker, Christine M., Rücker, Gerta, Sommer, Harriet, Virgili, Gianni, Loke, Yoon K., Oeller, Patrick, Agostini, Hansjuergen, Ehlken, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569266/ https://www.ncbi.nlm.nih.gov/pubmed/26368921 http://dx.doi.org/10.1371/journal.pone.0137866 |
Ejemplares similares
-
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
por: Schmucker, Christine, et al.
Publicado: (2012) -
Treatment of age-related neovascular macular degeneration: the patient’s perspective
por: Müller, S., et al.
Publicado: (2017) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023) -
Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Cummings, Michael, et al.
Publicado: (2008)